Meanness Thy Name is Donald Trump making Medicines cost a Bomb

Don’t please treat Health as a Trade War Pawn- Dr Aashish Chaudhry

New Delhi: Donald Trump has not covered himself with glory by imposing 100 percent tariffs on pharmaceutical imports. If he thinks he will achieve his MAGA, this meanness will always remain a festering sore on his country.

This measure of his could prove Trump’s unkindest cut on his own citizens he professes to protect. It is anti- theses to his so called peace overtures because 100 percent tariffs on medicines is a veritable act of war on hapless patients of America. It makes his overriding ‘Make America Great Again.’(MAGA) refrain a sham. It indeed raises a universal ethical question- Should patients be pitted to vagaries of trade war? Trump’s act is in stark contrast to that of PM Modi’s government which has just lowered the GST to make medicines more affordable to his patients.

Trump’s unbecoming act has rankled Dr Aashish Chaudhry, Managing Director, Aakash Healthcare. True healers all over the world will feel the same way what if only American patients are on the receiving end. Given the way trump is treating Indians in America now, average response might be- it serves an American right having to taste his own medicine. But for true healers, a patient is a patient wherever he belongs.

A renowned orthopedic surgeon Dr Chaudhry has picked a bone with Trump on this issue saying “The decision by the US President to impose a 100% tariff on pharmaceutical imports from Oct 1 is a blunt weapon.  While US patients may feel the pinch, it strikes at the heart of universal & affordable healthcare. Health should not be treated as a trade war pawn.’ As behoves a true healer, Dr Chaudhry here is fighting for American patients. Doctors of the world should rally around Dr Chaudhry’s little gesture of trying to save the world.

India may feel proud of the fact that over 90 percent Americans use cheap generic medicines produced by Indian Pharma Companies. Trump’s medicine madness will also badly impact the business of these Indian companies. Let us hope, Trump will heal himself and mend his obnoxious measure.

  • Related Posts

    IPC releases draft NFI-2026 to promote rational use of medicines

    Ghaziabad:- The Indian Pharmacopoeia Commission (IPC) has taken a significant step toward strengthening public health systems with the draft release of the National Formulary of India (NFI) 2026, a comprehensive…

    Laser rescued an Imperiled Food Pipe in Sir Ganga Ram Hospital

    An Impacted Denture accidently  had lodged inside it New Delhi: In a remarkable medical achievement, doctors at Sir Ganga Ram Hospital successfully removed an impacted dental plate that had accidentally…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Delhi Crime Branch Seizes Huge Stock Of Expired Baby Food, Cosmetics; One Arrested

    Delhi Crime Branch Seizes Huge Stock Of Expired Baby Food, Cosmetics; One Arrested

    FDA Releases Draft Guidance To Validate Non-Animal Testing Methods (NAMs) In Drug Development

    FDA Releases Draft Guidance To Validate Non-Animal Testing Methods (NAMs) In Drug Development

    IPC releases draft NFI-2026 to promote rational use of medicines

    IPC releases draft NFI-2026 to promote rational use of medicines

    Moonshot, SS Innovations displayed Battle Readiness for Monumental Goals in Robotic Surgery

    Moonshot, SS Innovations displayed Battle Readiness for Monumental Goals in Robotic Surgery

    US market to dent India pharma earnings even as domestic growth remains firm

    US market to dent India pharma earnings even as domestic growth remains firm

    Biocon Pharma receives USFDA approval for Dapagliflozin Tablets, 5 mg and 10 mg

    Biocon Pharma receives USFDA approval for Dapagliflozin Tablets, 5 mg and 10 mg